AI Article Synopsis
- The study aimed to evaluate the expression of BerEP4, a new antigen, in endometrial carcinoma cases.
- Researchers analyzed 45 cases using immunohistochemical methods, also assessing other antigens (CEA and TAG-72) for correlation with cancer characteristics.
- Results showed BerEP4 had no correlation with various cancer factors, despite CEA and TAG-72 showing some relationships with grading and histotype.
Article Abstract
Objective: To assess the immunochemical expression of BerEP4, a new epithelial antigen in endometrial carcinoma.
Methods: We studied 45 cases of endometrial carcinoma in which the BerEP4, CEA and TAG-72 antigens were searched by an immunohistochemical method. We evaluated the correlations among the immunohistochemical positivity and the grading, histotype, stage and receptorial status of the neoplasia.
Results: CEA was positive in 29 out of 45 cases (64.4%), TAG-72 in 17 out of 45 cases (37.7%) and BerEP4 in 31 out of 45 cases (68.9%). Both TAG-72 and CEA were inversely related to the grading while, with regard to the histotype, CEA resulted as highly positive in the 5 cases of adenoacanthoma.
Conclusion: BerEP4 did not show any correlation with grading, histotype, stage of disease or receptorial status of the carcinoma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!